bild
SCHWEIZ PHARMA ACTELION
Jean-Paul Clozel, CEO of Actelion Ltd. biopharmaceutical company based in Allschwil, Switzerland, informS the Media about the acquirement by Johnson & Johnson for $30 Billion with spin-out the new R&D Company on Thursday, January 26, 2017 at the Actelion Headquarter in Allschwil, Basel, Switzerland. (KEYSTONE/Patrick Straub)
Instruktionen
Lizenz
Rights Managed
Erstellungsdatum
20170126
Ort
ALLSCHWIL SCHWEIZ
Credit
KEYSTONE
Source
KEYSTONE
Byline
PATRICK STRAUB
Grösse
3630 x 2420 px
Dateityp
JPEG